Esophageal motor disorders

Current Opinion in Gastroenterology

Volumn 17, Issue 4, 2001, Pages 366-375

  Prakash, C ^a   Clouse, R E ^a  

^a Division of Gastroenterology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; BARIUM; BOTULINUM TOXIN; CD3 ANTIGEN; CD8 ANTIGEN; COLLAGEN; DOXYCYCLINE; FERROUS SULFATE; GRANZYME B; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM CHLORIDE; QUINIDINE; SPASMOLYTIC AGENT; TETRACYCLINE DERIVATIVE;

ANTIREFLUX OPERATION; BALLOON DILATATION; CLINICAL TRIAL; DYSPHAGIA; ENDOSCOPY; ESOPHAGITIS; ESOPHAGOGRAPHY; ESOPHAGUS; ESOPHAGUS ACHALASIA; ESOPHAGUS DISEASE; ESOPHAGUS INJURY; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS MYOTOMY; ESOPHAGUS SPASM; GASTROESOPHAGEAL REFLUX; HUMAN; LAPAROSCOPIC SURGERY; LOWER ESOPHAGUS SPHINCTER; NONHUMAN; REVIEW; STOMACH FUNDOPLICATION; STROKE; SYMPTOMATOLOGY; UPPER ESOPHAGUS SPHINCTER;

EID: 0034935439     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200107000-00012     Document Type: Review

References (60)

1. Esophageal motility disorders: Current concepts of pathogenesis and treatment
2. Motor disorders of the esophagus
3. Functional anatomy and physiology of the upper esophageal sphincter
4. Manometry of the upper esophageal sphincter and pharynx is not useful in unselected patients referred for esophageal testing
5. Clinical utility of the modified barium swallow
6. The safety of flexible endoscopic evaluation of swallowing with sensory testing (FEESST): An analysis of 500 consecutive evaluations
7. Prospective, randomized outcome study of endoscopy versus modified barium swallow in patients with dysphagia
8. Bread and barium: Diagnostic value in patients with suspected primary esophageal motility disorders
9. Digital radiography in the evaluation of esophageal motility disorders
10. Radionuclide esophageal transit test to detect esophageal disorders in patients with mitral valve prolapse
11. Evidence of abnormal esophageal motility in syndrome X by radionuclide esophageal transit test
12. Esophageal and gastric dysmotility in non ulcer dyspepsia
13. Accurate placement of the esophageal pH electrode for 24-hour pH monitoring using a combined pH/manometry probe
14. Evaluation of the lower esophageal sphincter pressure using endoscopic manometric sleeve assembly
15. Topographic esophageal manometry: An emerging clinical and investigative approach
16. Application of topographic methods to clinical esophageal manometry
17. Swallowing disorders following acute stroke: Prevalence and diagnostic accuracy
18. Dysphagia in children with a 22q11.2 deletion: Unusual pattern found on modified barium swallow
19. Dysphagia lusoria: Clinical aspects, manometric findings, diagnosis, and therapy
20. Evaluation and treatment of swallowing impairments
21. Inter- and intrajudge reliability of a clinical examination of swallowing in adults
22. Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia
23. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I: Conceptual foundation and item development
24. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II: Item reduction and preliminary scaling
25. Evaluation of the benefits of monitoring fluid thickness in the dietary management of dysphagic stroke patients
26. Effectiveness of feeding tubes in nursing home residents with swallowing disorders
27. Interventions for dysphagia in acute stroke
28. Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction
29. Botulinum toxin injection of the cricophayngeus muscle for the treatment of dysphagia
30. Management of upper esophageal sphincter disorders: Indications and complications of myotomy
31. Primary cricopharyngeal achalasia in infancy-myotomy treatment of choice
32. Esophageal motor disorders
33. Cricopharyngeal myotomy does not increase the risk of esophagopharyngeal acid regurgitation
34. The nature of the myenteric infiltrate in achalasia: An immunohistochemical analysis
35. Characterization of esophageal striated muscle in patients with achalasia
36. Cardiovascular autonomic function in patients with primary achalasia
37. Complete lower esophageal sphincter relaxation observed in some achalasia patients is functionally inadequate
38. Esophageal tone in patients with total aperistalsis: Gastroesophageal reflux disease versus achalasia
39. Diagnosis of primary versus secondary achalasia: Reassessment of clinical and radiographic criteria
40. A multicenter randomized study of intrasphincteric botulinum toxin in patients with esophageal achalasia: GISMAD Achalasia Study Group
41. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: A survival analysis approach
42. Predictors of response to pneumatic dilatation in achalasia cardia
43. Cardiomyotomy
44. Treatment of esophageal achalasia with laparoscopic Heller myotomy and Dor partial anterior fundoplication: Prospective evaluation of 100 consecutive patients
45. Laparoscopic esophageal surgery
46. Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for esophageal achalasia
47. Laparoscopic Heller myotomy for achalasia
48. Laparoscopic esophagomyotomy for the treatment of achalasia in children: A preliminary report of eight cases
49. Motility-modifying agents and management of disorders of gastrointestinal motility
50. Expandable metal stents in achalasia - Is there a role?
51. Topographic analysis of esophageal double-peaked waves
52. Hiatus hernia: A review of evidence for its origin in esophageal longitudinal muscle dysfunction
53. Hiatus hernia and esophageal contraction abnormalities
54. The short- and long-term efficacy of empirical esophageal dilation in patients with nonobstructive dysphagia: A prospective, randomized study
55. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (scleroderma)
56. Cardiovascular autonomic function, autoantibodies, and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease
57. Bolus transit assessed by an esophageal stress test in postfundoplication dysphagia
58. Effect of an esophageal bougie on the incidence of dysphagia following Nissen fundoplication: A prospective, blinded, randomized clinical trial
59. Heartburn is more likely to recur after Toupet fundoplication than Nissen fundoplication
60. Drug-induced esophageal disorders: Pathogenesis, incidence, prevention and management